+149.3%
CBRE vs BBIO
+148.4%
+0.9%
-53.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -2.8% | +1.5% | -0.9% |
| 7D | -4.8% | -2.9% | -1.9% | -4.5% |
| 30D | -5.9% | +12.2% | -18.1% | -7.1% |
| 3M | -16.5% | -8.3% | -8.2% | -15.8% |
| 6M | -3.4% | +11.4% | -14.8% | -4.9% |
| YTD | -21.2% | -0.6% | -20.6% | -22.0% |
| 1Y | -16.4% | +17.7% | -34.1% | -18.8% |
| 3Y | +62.2% | +160.0% | -97.8% | +40.7% |
| 5Y | +27.1% | +78.3% | -51.2% | -3.1% |
| All | +149.3% | +148.4% | +0.9% | +56.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling